Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) have been sharply rising on the charts following the release of encouraging clinical trial results. Its stock price
As of the last check during the recent trading session, Phio Pharmaceuticals Corp. (NASDAQ: PHIO) shares were up 33.81% to $2.36, indicating a big increase
On Friday, hot penny stock Phio Pharmaceuticals Corp. (PHIO) fell under corrections after its spiked up in regular trading. The company announced new data on
Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter
Immutep Limited (NASDAQ: IMMP) shares are trading down -26.19% at $4.2 at the time of writing after reporting that its Chinese partner, EOC Pharma will
FuelCell Energy Inc. (FCEL) stock soared 7.34% to $4.02 in the pre-market trading. The most recent rating by JP Morgan, on October 08, 2020, is
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.